GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cann Group Ltd (OTCPK:CNGGF) » Definitions » Valuation Rank

CNGGF (Cann Group) Valuation Rank


View and export this data going back to 2017. Start your Free Trial

What is Cann Group Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Cann Group Valuation Rank Related Terms

Thank you for viewing the detailed overview of Cann Group's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Cann Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cann Group Ltd (OTCPK:CNGGF) » Definitions » Valuation Rank
Comparable Companies
ASX:PER ASX:AGH ASX:ECS ASX:RGT ASX:EOF ASX:IVX ASX:EXL ASX:BP8 ASX:NXS ASX:LGP ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
CVJ:Germany CAN:Australia
Address
262-276 Lorimer Street, Ground Floor, Port Melbourne, VIC, AUS, 3207
Website
https://www.canngrouplimited.com
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.